Cosmetic Peptide Manufacturing Market: Projected Growth to Reach US$ 411.9 Million by 2034 | Future Market Insights, Inc.

Key Players are Expanding their Dermocosmetics Portfolio by Offering Unique and Differentiated Solutions in Cosmetic Peptide Manufacturing Market. Global Cosmetic Peptide Manufacturing Market shows robust growth trends, driven by skincare demand, innovation, and regional expansion.


NEWARK, Del, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The global cosmetic peptide manufacturing market value is expected to rise from US$ 244.2 million in 2024 to US$ 411.9 million by 2034. This estimated growth is expected to be driven by a CAGR of 5.4% over the next decade.

Research and development investment is a crucial supply-side driver that significantly impacts the growth and development of the global cosmetic peptide manufacturing market. These investments are aimed at the allocation of resources, both financial and human, towards exploring new scientific advancements, formulations, and applications related to peptide-based cosmetics.

Key players in the market are offering new cosmetic peptide blends with higher efficacy levels to target a greater consumer base. Moreover, companies are studying the current market requirements and taking a customization route to deliver solutions as per specific skincare needs. This approach allows for higher customer satisfaction and repeat sales.

To Get a Sample Copy of the Report Visit: https://www.futuremarketinsights.com/reports/sample/rep-gb-18528

The increasing use of cosmetic peptides in various skin care products is raising its production. Key players are increasing their peptide offering for commercial supply and charting into difficult-to-develop peptides. This is fueling cosmetic peptide manufacturing across the globe.

High throughput production and manufacturing of personalized peptides are the key focus areas of leading players. Manufacturers of cosmetic peptide are expected to find profitable prospects in East Asia, particularly in China.

“The ongoing research and development is leading to advancements in peptide manufacturing technology, which is responsible for the expansion of cosmetic peptide manufacturing,” Says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.)

Key Takeaways from the Cosmetic Peptide Manufacturing Market Report

  • By product, the signal peptides hold a lucrative forecast CAGR value of 5.5%. The segment accounted for a market share of 55.3% in 2023.
  • By application, the anti-aging series peptides hold a 26.9% market value in 2023. Growing demand for products that promote youthful-looking skin is contributing to this segment’s growth.
  • By end product, skin care holds a significant segment share in terms of the market value of 53.1% in 2023. The skin care segment is a dominant force in the cosmetic industry, driven by consumer demand for products that address various skin concerns.
  • Among end users, the cosmetic manufacturers segment dominates the market with the highest share, accounting for 47.6% of the market share value in 2023. This is attributed to their integration of peptides into formulations, aligning with consumer demands for effective skincare products.
  • North America emerges as the primary region, holding a substantial value share of 29.0% in 2023. This is driven by the rising popularity and adoption of cosmetic products, resulting in increased sales across the region.

Strategic Plan to Conquer a Larger Share in the Cosmetic Peptide Manufacturing Market

Various pharmaceutical and biopharmaceutical companies are focusing on a research-based collaborative approach for the development of their products for various industrial applications. To increase the quality, affordability, and sustainability of their products and expand sales worldwide, several market players are strategically entering into collaborative agreements.

  • In July 2023, Chlitina, a Taiwanese beauty company, launched a new personal care brand that features microbiome-friendly peptide derived from human saliva.
  • In January 2021, BASF entered into a worldwide, exclusive supply pact with Caregen for four cosmetic peptides addressing anti-aging, anti-pigmentation, atopic-prone, and acne-prone skin concerns. This strategic agreement is part of BASF's initiative to broaden its dermocosmetics portfolio.

Methodology Details Just a Click Away! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-18528

Restraints:

Despite the promising growth trajectory, regulatory complexities and stringent approval processes associated with peptide-based cosmetics might impede market expansion. Additionally, the high cost of research and development for innovative peptide formulations could pose challenges to smaller players in entering the market.

Leading Companies in Cosmetic Peptide Manufacturing Market

  • Croda International Plc
  • Ashland
  • DSM [Koninklijke DSM NV]
  • Bachem
  • Genscript Biotech Corp
  • BASF SE
  • Geltor
  • The Lubrizol Corporation
  • Symrise
  • Bio basic Inc.
  • Regeron Inc.
  • Merck KGaA
  • RS Synthesis, LLC
  • CSBio Company Inc.
  • Creative Peptides
  • Spec Chem Industry Inc.
  • LipoTrue, SL
  • Fibroheal
  • Seiwa Kasei Co., Ltd.
  • Silab
  • Others

Key Market Segments Covered in Cosmetic Peptide Manufacturing Market Report

By Product:

  • Signal Peptides
  • Neurotransmitter Inhibitors
  • Carrier Peptides
  • Enzyme Inhibitor Peptides
  • Structural Peptides
  • Synthetic Antimicrobial Peptides (Amps)
  • Others

By Application:

  • Hair/Eyelash/Eyebrow Care Series Peptide
  • Whitening Series Peptides
  • Anti-Aging Series Peptides
  • Skin Renewal Series Peptides
  • Anti-allergic and Anti-Inflammatory Series Peptide
  • Slimming and Breast Enhancement Peptides
  • Others

By End Product:

  • Skin Care
    • Creams and Moisturizers
    • Sunscreen lotions
    • Serums
  • Hair Care
    • Creams
    • Serums
  • Eye Care
    • Creams
    • Serums

By End User:

  • Cosmetic Manufacturers
  • Cosmetic Contract Manufacturers
  • Biopharmaceutical Industries (Personal care)

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia and Pacific
  • Western Europe
  • Eastern Europe
  • Central Asia
  • Russia and Belarus
  • Balkan and Baltic Countries
  • Middle East and Africa

Access Exclusive Market Insights - Purchase now: https://www.futuremarketinsights.com/checkout/18528

Authors

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise slies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News

Have a Look at Top Reports in the Healthcare Domain:

Ultra-fine Medical Wire Market size was valued at US$ 237.9 million in 2022 and is expected to reach US$ 466.2 million by 2033. It is set to rise at a CAGR of close to 6.4% over the forecast period (2023 to 2033).

Antacids Market is expected to be worth US$ 6,971.2 million by the end of 2023 and further expand at a CAGR of 4.9% to reach a valuation of US$ 11,194.8 million by 2033.

Soft Tissue Repair Market is set for significant expansion, with an anticipated valuation of US$ 6,992.8 million by 2023. The market displays a significant trend, with a rise in CAGR of 4.5%, expected to endure until 2033.

Anti-aging Vitamins Market was valued at US$ 1.4 billion in 2022. The market is expected to expand at a CAGR of 8.8% and reach a valuation of US$ 3.5 billion by 2033.

CTNG Testing Market is worth US$ 1.8 billion in 2023 and is expected to reach US$ 3.9 billion by 2033. The demand for CTNG testing is anticipated to rise at a CAGR of 8.0% from 2023 and 2033.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube